Type in any company name or organization to see related SEC FOIA activity. A B7A exemption indicates a potential undisclosed SEC investigation. Learn more in this video.

Stay Updated

Get notified when new results match your search terms

Join ... investors getting FOIAsearch.com alerts on their portfolio
... searches processed so far
Total Results:68,456B7A Results:2,778

Request Types

  • FOIA:20,959
  • Exhibit:21,154
  • Triage:20,362
  • FOIA/PA:1,727
  • Remand:579
  • OIG Requests:128
  • FIFO:107
  • COVID-19:177
  • Government Referrals:56
  • Requests for Congressional Records:230
  • Consultation:90
  • Congressional:12
  • First-Party IG Requests:12
  • FOPA:45
  • Not Provided:2,754
  • Chairman Correspondence:23
  • Privacy Act Amendment:16
  • REMD:13
  • CFOI:6
  • OIG:2
  • GOVT:3
  • CHAI:1

Top Organizations

  • Probes Reporter, LLC:15,945
  • Not Provided:11,972
  • AUS Consultants, Inc.:4,362
  • Knowledge Ecology International (KEI):3,960
  • Check Fund Manager, LLC:3,217

Dispositions

  • Granted/Denied in Part:1,332
  • Other Reasons:26,371
  • Denied in Full:4,433
  • Granted in Full:13,760
  • Not Provided:21,180
  • Denied in Full - Referred to the web:1
  • Denied in Full - No information found (appeal rights):3
  • Other Reasons - Cancelled:23
  • Other Reasons - No information found (appeal rights):1,159
  • Other Reasons - Withdrawn:10
  • Other Reasons - Referred to the web:28
  • Other Reasons - Referred to another agency:22
  • Other Reasons - GLOMAR:63
  • Other Reasons - Not an agency record:7
  • Other Reasons - Referred to another office:3
  • Granted in Full - No information found (appeal rights):5
  • Other Reasons - Duplicate Request:39
  • Other Reasons - Not a proper FOIA request for some other reason:5
  • Other Reasons - Records lost or destroyed:2
  • Other Reasons - NIF (c)(1)Exclusion:1
  • Granted/Denied in Part - No information found (appeal rights):1
  • Other Reasons - Records are not reasonably described:3
  • Other Reasons - Moot:1
  • Other Reasons - Referred to Court:2
  • Other Reasons -:1
  • Other Reason:1

All Requests

68,456 results
Requested Date: 5/26/2025Closed Date: 6/5/2025Requester: Poorna, NagaOrganization: ClarivateType: ExhibitDisposition: Other ReasonsRequest ID: 25-02625-E
Description:Exhibit 10.1 to Form 8-K, filed by Palatin Technologies, Inc., on July 27, 2020
Requested Date: 5/30/2025Closed Date: 6/5/2025Requester: Harutyunyan, AniOrganization: DealFormaType: ExhibitDisposition: Granted in FullRequest ID: 25-02766-E
Description:previous request number: 18-03631-E for Exhibit 10.35, to the December 31, 2014 10-K, filed by Celladon Corp. (now called Eiger BioPharmaceuticals, Inc.), on March 31, 2015
Requested Date: 5/30/2025Closed Date: 6/5/2025Requester: Harutyunyan, AniOrganization: DealFormaType: ExhibitDisposition: Granted in FullRequest ID: 25-02782-E
Description:previous request number: 18-04344-E for Exhibit 10.1, to the March 31, 2015, 10-Q, filed by Tokai Pharmaceuticals, Inc. (now called Novus Therapeutics, Inc.), on May 12, 2015
Requested Date: 5/28/2025Closed Date: 6/4/2025Requester: Gil, LuisOrganization: -Type: ExhibitDisposition: Granted in FullRequest ID: 25-02647-E
Description:Exhibit 10.3 to the Form 8-K filed by Infinity Pharmaceuticals, Inc., on September 18, 2006, as previously released in 20-01662-E
Requested Date: 5/30/2025Closed Date: 6/4/2025Requester: Brozyna, MalgorzataOrganization: RoyaltyStat LLCType: ExhibitDisposition: Other ReasonsRequest ID: 25-02737-E
Description:Exhibit 10.7 to Form F-1, filed on April 5, 2022, by Belite Bio, Inc.
Requested Date: 5/30/2025Closed Date: 6/4/2025Requester: Brozyna, MalgorzataOrganization: RoyaltyStat LLCType: ExhibitDisposition: Other ReasonsRequest ID: 25-02738-E
Description:Exhibits 10.1 and 10.2 to Form 10-Q, filed on August 13, 2015, by Chromadex Corp.

B7A Exempt Requests

2,778 results
Requested Date: 6/16/2023Closed Date: 5/30/2025Requester: Yardis, MorganOrganization: Protect The Public�s TrustType: FOIADisposition: Granted/Denied in PartRequest ID: 23-02683-FOIA
Description:records of communications since November 15, 2022, involving Erik Gerding that contain the following search terms: Make America Great Again; MAGA; and "Trump"
Requested Date: 10/10/2024Closed Date: 5/30/2025Requester: Kupchun, StephenOrganization: -Type: FOIADisposition: Denied in FullRequest ID: 25-00104-FOIA
Description:any emails sent to and from email domain SEC.GOV containing the term"MMTLP" in the subject line or the body of the email from 11/1/2022 - 12/9/2022
Requested Date: 12/12/2024Closed Date: 5/30/2025Requester: Wright, JeffOrganization: -Type: FOIADisposition: Denied in FullRequest ID: 25-00928-FOIA
Description:all reports, audits, and compliance documentation related to related to FINRA concerning $MMTLP
Requested Date: 2/11/2025Closed Date: 5/30/2025Requester: Swanson, BenjaminOrganization: -Type: FOIADisposition: Denied in FullRequest ID: 25-01505-FOIA
Description:any emails, attachments, sent or received by Richard Boyle, associated with FINRA's Market Fraud Investigations team, and Sam Draddy, in regards to communications related to MMTLP, MMAT, and topics concerning fraud or illegal short shares
Requested Date: 4/16/2025Closed Date: 5/30/2025Requester: Belayneh, MekedasOrganization: Center for International PolicyType: FOIADisposition: Granted/Denied in PartRequest ID: 25-02247-FOIA
Description:the Division of Enforcement or any relevant SEC office regarding the closure, dismissal, or conclusion of investigations or enforcement actions involving Gemini / Genesis Global Capital in calendar year 2025
Requested Date: 4/17/2025Closed Date: 5/30/2025Requester: Humes, GarrettOrganization: -Type: FOIADisposition: Denied in FullRequest ID: 25-02263-FOIA
Description:any and all correspondence between the SEC (Securities Exchange Commission) and FINRA (Financial Industry Regulatory Authority) in regards to the U3 - Extraordinary Event Halt related to ticker symbol MMTLP pursuant to Rule 6440(a) (3)